Profil
Itai Danovitch currently works at Science 37, Inc., as Director and Bexson Biomedical, Inc., as Director.
Postes actifs de Itai Danovitch
| Sociétés | Poste | Début |
|---|---|---|
Science 37, Inc.
 Science 37, Inc. BiotechnologyHealth Technology Science 37, Inc. develops mobile technology, clinical trials and patient-centric models for clinical research. It focuses on the development of networked patient-centric models for clinical research to accelerate biomedical discovery. The firm develops Network Oriented Research Assistant, which bridges the gap between traditional trial management software and an advanced telemedicine platform; supports end-to-end management of networked clinical trials; and allows researchers to communicate with patients and mobile nurses from homes using videos, photographs, survey forms, or device data capture on iPhones, iPads, or Android devices. The company was founded by Noah Craft and Belinda Tan and is headquartered in Culver City, CA. | Directeur/Membre du Conseil | - |
Bexson Biomedical, Inc.
 Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Science 37, Inc.
Science 37, Inc. BiotechnologyHealth Technology Science 37, Inc. develops mobile technology, clinical trials and patient-centric models for clinical research. It focuses on the development of networked patient-centric models for clinical research to accelerate biomedical discovery. The firm develops Network Oriented Research Assistant, which bridges the gap between traditional trial management software and an advanced telemedicine platform; supports end-to-end management of networked clinical trials; and allows researchers to communicate with patients and mobile nurses from homes using videos, photographs, survey forms, or device data capture on iPhones, iPads, or Android devices. The company was founded by Noah Craft and Belinda Tan and is headquartered in Culver City, CA. | Health Technology |
Bexson Biomedical, Inc.
Bexson Biomedical, Inc. BiotechnologyHealth Technology Bexson Biomedical, Inc. is a research stage company based in Santa Barbara, CA. The company is focused on developing BB106, a ketamine therapy for pain management and mental health disorders. The company is also applying their proprietary delivery platform to several psychedelic and non-psychedelic compounds to reduce suffering caused by pain, addiction, and mental health conditions. The company was founded by Jeffrey Becker and Gregg Peterson has been the CEO of the company since 2019. | Health Technology |
